Skip to main content
. 2021 Jul 12;5(1):e190. doi: 10.1017/cts.2021.813

Fig. 2.

Fig. 2.

Characteristics of urban and rural participants and study risks. Panel A. Proportion of rural (gray) and urban (black) trial participants (left) at the three Mayo Clinic sites, (middle) among women and men, and (right) among the elderly. Panel B. Distribution of rural and urban participants among trials associated with specific risks. FDA, US Food and Drug Administration.